Ceredex Value Advisors’s Entegris ENTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5M Sell
147,150
-42,350
-22% -$6.11M 0.75% 43
2026
Q1
$22.2M Buy
+189,500
New +$22.4M 0.7% 55
2021
Q2
Sell
-36,698
Closed -$4.1M 145
2021
Q1
$4.1M Sell
36,698
-17,300
-32% -$1.78M 0.05% 118
2020
Q4
$5.19M Sell
53,998
-176,202
-77% -$15.4M 0.07% 113
2020
Q3
$17.1M Sell
230,200
-1,400
-0.6% -$93.8K 0.25% 94
2020
Q2
$13.7M Buy
231,600
+177,400
+327% +$9.85M 0.2% 102
2020
Q1
$2.43M Buy
+54,200
New +$2.81M 0.04% 111

Other funds holding ENTG

Ceredex Value Advisors's ENTG Position: Q2 2026 in Review

Ceredex Value Advisors reduced its Entegris (ENTG) stake by 22% in Q2 2026, selling an estimated $6.11M and leaving 147,150 shares worth $26.5M. The position accounts for 0.75% of the portfolio, ranked #43.

Ceredex Value Advisors first reported a position in ENTG in Q1 2020 and has held it in 7 quarters since. 744 funds tracked by Wall St. Rank hold ENTG as of Q2 2026.

  • Ceredex Value Advisors held 147,150 shares of Entegris worth $26.5M as of Q2 2026.
  • Ceredex Value Advisors sold 42,350 Entegris shares in Q2 2026, an estimated $6.11M.
  • Entegris made up 0.75% of Ceredex Value Advisors's portfolio in Q2 2026, its #43 holding.
  • Ceredex Value Advisors first reported a position in Entegris in Q1 2020 and has held it in 7 quarters since.
  • 744 funds tracked by Wall St. Rank held Entegris as of Q2 2026.

Based on Ceredex Value Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.